ATON Biotech
About Us
Aton (Shanghai) Biotech Co., Ltd. is a rapidly expanding global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) that prioritizes quality in every aspect of its operations. Aton empowers integrated biopharmaceutical drug development and manufacturing, helping customers to accelerate their pipelines to market worldwide. Aton offers comprehensive CDMO services, from cell line construction to commercial manufacturing, encompassing monoclonal antibodies, fusion proteins, bispecific antibodies, Antibody Drug Conjugates (ADCs), and more. With its fully integrated single-source solution, Aton is able to speed up the market launch of more programs while reducing risks, time, and costs.
Aton is equipped with 2 R&D and commercial manufacturing facilities, all supported by a quality management system that meets global standards set by the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Chinese National Medical Products Administration (CNMPA).
Mission
Enable Innovation from Concept to Market with Quality and Speed
Vision
Become the CDMO of choice for the global biopharmaceutical industry
- 70+IND Approved GloballyFDA, EMA, NMPA
- 150+Scale Toxicology and Clinical Production Experience
- 99%+Manufacturing
Success Rate - 50+MoleculesmAb, BsAb, Antibody Fragments, Fusion Proteins, ADC etc.
- 1000+Commercial Batches Production Experience
- 90+Approved by Global Regulatory and Partner Audits
Company Team
In addition to the industry-leading manufacturing technology platforms, Aton Biotech has established an international level biomedical R&D, production, and operation management team, with high-quality talent reserve and robust team structure. The core management team has more than 15 years of senior management and industry experience in drug R&D, clinical, production, CMC, quality, and compliance from leading multinational pharmaceutical companies.